U.S. market Open. Closes in 3 hours 9 minutes

PASG | Passage Bio, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
RevenueN/AN/AN/AN/AN/AN/A
Cost of Revenue3.72M3.68M1.54M800.00K134.00KN/A
Gross Profit-3.72M-3.68M-1.54M-800.00K-134.00KN/A
Operating Expenses108.39M135.39M177.73M111.90M36.69M10.10M
Selling, General & Admin41.58M49.34M60.06M30.11M6.95M928.00K
Research & Development61.42M86.05M117.67M81.79M29.74M9.17M
Other Operating Expenses5.39MN/AN/AN/AN/AN/A
Operating Income-108.39M-138.39M-185.73M-112.90M-37.19M-13.47M
Other Expenses / Income6.33M2.27M343.00K670.00K-8.45M-2.67M
Before Tax Income-102.06M-136.12M-185.39M-112.23M-45.63M-12.77M
Income Tax Expenses5.39M731.00K6.11M-470.00K8.95M-696.00K
Net Income-102.06M-136.86M-191.50M-111.76M-54.58M-12.77M
Interest ExpensesN/A2.27MN/AN/AN/A-696.00K
Basic Shares Outstanding54.74M54.43M53.34M38.62M45.80M23.96M
Diluted Shares Outstanding54.74M54.43M53.34M38.62M45.80M23.96M
EBITDA-99.28M-132.39M-169.73M-110.90M-26.91M-7.42M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-96.67M-133.86M-185.39M-112.23M-45.63M-14.16M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙